Biotransformation of BMOV in the presence of blood serum proteins
Author(s) -
Daniele Sanna,
Linda Bíró,
Péter Buglyó,
Giovanni Micera,
Eugenio Garribba
Publication year - 2011
Publication title -
metallomics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.012
H-Index - 75
eISSN - 1756-591X
pISSN - 1756-5901
DOI - 10.1039/c1mt00161b
Subject(s) - biotransformation , chemistry , in vivo , human blood , blood proteins , biochemistry , enzyme , biology , physiology , microbiology and biotechnology
The interaction of the potent anti-diabetic agent bis(maltolato)oxidovanadium(IV) (BMOV) with some proteins of blood serum was studied by EPR spectroscopy, pH-potentiometry and DFT calculations. The formation of cis-VO(ma)(2)(hTf), cis-VO(ma)(2)(HSA) and cis-VO(ma)(2)(IgG), their role in the biotransformation in vivo and the mechanism of transport of BMOV in blood are discussed.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom